recent post

Herbalife India, IIT Madras launch 1,000 data science scholarships

November 4, 2024
recent post

KIMSHEALTH Nagercoil launches modular OT complex

recent post

Bayer introduces Bepanthen in India to tackle dry skin

recent post

SECL's CSR initiative completes heart surgeries for 20 children

November 1, 2024
recent post

Parexel names Keri Mattox as Chief Business Officer

RGCIRC aims to set up corpus of Rs 300 Cr over three years for cancer care

RGCIRC aims to set up corpus of Rs 300 Cr over three years for cancer care

Interest earned from it is to be utilised for the treatment of underprivileged section At a conference held at its Rohini Centre, Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) unveiled a comprehensive plan to foster partnerships aimed at making quality cancer care more accessible and affordable. Rakesh Chopra, Chairman, RGCIRC, highlighting the hospital's genesis as a testament to philanthropic endeavours, said, "RGCIRC stands as a prime example of a hospital born out of philanthropy. With an initial contribution of just Rs 49 lakh, the hospital has achieved significant milestones since its incorporation. We have a corpus of Rs 100 crore and our goal is to expand this corpus to Rs 300 crore within the next three years. The interest accrued will be utilised to support economically disadvantaged patients." DS Negi, CEO, RGCIRC, emphasised the unique ethos of the hospital, stating, “The very seeds of our hospital are sown in philanthropy. We are a hospital with a difference as we ensure equitable treatment for all patients. We have spent around Rs 44 crore from our funds for the treatment of underprivileged individuals. Every contribution and support we receive is channelled towards aiding the underprivileged, and it remains our key motto.” Dr Sudhir Rawal, MD, RGCIRC, discussed the groundbreaking advancements in cancer treatment at RGCIRC. “RGCIRC is the first in the country to introduce cutting-edge technologies like High-Intensity Focused Ultrasound (HIFU), robotic surgery, cyber knife and others. We are actively working towards the development of indigenous Car T cell therapy soon, and through these advancements, we continue to provide world-class oncology care,” said Dr Rawal. Highlighting RGCIRC's journey in philanthropy, a booklet titled A Sun Rises in Cancer was released, offering inspiration and insight into the institute's charitable endeavours. Under the banner of enhancing care and facilitating early detection and treatment, the conference brought together a consortium of medical experts, industry leaders, and corporate stakeholders. This gathering underscored the critical importance of Corporate Social Responsibility (CSR) in advancing cancer care, particularly for those in dire financial need. The event was graced by distinguished guests such as Dr Sayed Humayun Jafri, Ex-head of CSR, PR & International Patient Advisor-Tata Memorial Hospital Mumbai and other dignitaries including Vivek Awasthi, GM (CSR), Engineers India Limited (EIL), Akhil Gupta, Deputy General Manager, (Admin), Human Resources Services, NR– Bharat Petroleum Corporation Limited (BPCL), and representatives from Indian Oil Corporation Limited (IOCL) Oil and Natural Gas Corporation (ONGC). These leaders reiterated their commitment to supporting RGCIRC's mission, emphasising the collective responsibility to ensure equitable access to quality cancer care.